Results 121 to 130 of about 50,813 (296)

Untargeted Metabolomic Profiling, Multivariate Analysis and Biological Evaluation of the True Mangrove (Rhizophora mucronata Lam.)

Antioxidants, 2019
Currently, there is a renewed interest towards the development of plant-based pharmacophores. In this work, 16 extracts prepared from the leaves, twigs, roots and fruits of a hydro-halophyte, Rhizophora mucronata Lam.
Nabeelah Bibi Sadeer, Gabriele Rocchetti, Biancamaria Senizza, Domenico Montesano, Gokhan Zengin, Ahmet Uysal, Rajesh Jeewon, Luigi Lucini, Mohamad Fawzi Mahomoodally   +8 more
doaj   +1 more source

Hyperpigmentation and hypotension

Cleveland Clinic Journal of Medicine, 2012
A 65-year-old man presents after 2 months of weakness, dizziness, and blurred vision. What test should be ordered?
Khaldoon, Shaheen, Abdul Hamid, Alraiyes, Motaz, Baibars, M Chadi, Alraies   +3 more
openaire   +2 more sources

Skin Lightening Treatments: A Review on the Effect of Intravenous Glutathione in the Disease States of Women [PDF]

, 2020
The skin bleaching industry is a global business with a vast array of anti-melanogenic choices including glutathione. Glutathione is synthesized in vivo but has been used as a bodily supplement by medical personnel to aid in preventative medicine.
Mthombeni, Buhle
core   +1 more source

Novel Histopathologic Features of Diffuse Blue‐Gray Hyperpigmentation Associated With Kratom Use: A Case Report and Literature Review

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Drug‐induced hyperpigmentation accounts for 10%–20% of acquired pigmentary disorders and can be misdiagnosed for other causes such as melasma, post inflammatory changes, or heavy metal deposition. Kratom (Mitragyna speciosa), a Southeast Asian plant with an opioid‐like profile, has been increasingly used in the United States for ...
Rita Kamoua, Kristen Paradine, Craig A. Rohan, Mary McDaniel, Diane Perkins   +4 more
wiley   +1 more source

National Delphi consensus on laser and energy‐based treatments for rosacea

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background Various treatments are available for rosacea, including lasers and energy‐based devices (EBDs). However, the specific role of lasers and EBDs in rosacea management remains insufficiently defined in Germany. The aim of the study was to develop a comprehensive expert consensus on the use of lasers and EBDs in the treatment of rosacea ...
Lynhda Nguyen, Nikolaus Seeber, Uwe Paasch, Martin Schaller, Claudia Borelli, Syrus Karsai, Gerd Kautz, Tanja C. Fischer, Michael Drosner, Stefan Hammes, Konstantin Feise, Christian Raulin, Martina Kerscher, Gerd Gauglitz, Jens M. Baron, Stefan W. Schneider, Katharina Herberger   +16 more
wiley   +1 more source

The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates

Clinical, Cosmetic and Investigational Dermatology, 2018
Adeolu Oladayo Akinboro,1 Ogochukwu Ifeanyi Ezejiofor,2 Fatai Olatunde Olanrewaju,3 Mufutau Muphy Oripelaye,3 Olatunde Peter Olabode,4 Olugbenga Edward Ayodele,4 Emmanuel Olaniyi Onayemi3 1Dermatology Unit, Department of Internal Medicine, Ladoke ...
Akinboro AO, Ezejiofor OI, Olanrewaju FO, Oripelaye MM, Olabode OP, Ayodele OE, Onayemi EO   +6 more
doaj  

Allgrove Syndrome with Absent Adrenal Gland in a Child: A Case Report

Indian Pediatrics Case Reports
Background: Allgrove syndrome is an autosomal recessive disorder caused by mutation in AAAS gene and characterized by alacrimia, achalasia, and adrenal insufficiency. Subtle clinical features may be the only findings and need good workup.
Medha Mittal, Ishani Agrawal, Anuradha Rai, Gulab Singh, Priyanka Prasad, Parveen Gulati   +5 more
doaj   +1 more source

S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary This second part of the S3 guideline on the diagnosis and treatment of alopecia areata (AA), presents key recommendations on topical and systemic therapy, quality of life and support services. The first part of the guideline, published separately, covers the definition and content of epidemiology and diagnosis as well as comorbidities, risk and
Ulrike Blume‐Peytavi, Andria Constantinou, Tsenka Tomova‐Simitchieva, Adrian Tanew, Michael Sticherling, Hermann Girschick, Annika Vogt, Uwe Schwichtenberg, Uwe Gieler, André Märtens, Kerstin Zienert, Claudia Stenders, Ricardo Niklas Werner, Doris Wilborn   +13 more
wiley   +1 more source

Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical Experience

European Journal of Haematology, EarlyView.
ABSTRACT Patients with relapsed/refractory (R/R) diffuse large B‐cell lymphoma (DLBCL) who progress to the third‐line setting face a lack of standardized treatment, despite the presence of multiple available therapies. In this context, antibody–drug conjugates represent a relatively new class of anticancer agents; among them, loncastuximab tesirine is ...
Francesca Bonello, Andrea Aroldi, Alessia Castellino, Lara Mannelli, Elia Boccellato, Serena Rosati, Luisa Verga, Umberto Vitolo   +7 more
wiley   +1 more source

Nanotechnology-Powered Cosmetics: Progress in Hyperpigmentation Treatment

Precision Nanomedicine
Hyperpigmentation is a prevalent and notable skin issue affecting individuals across all skin types. Although several depigmentation agents are available to address hyperpigmentation, their effectiveness is limited due to inadequate skin absorption and ...
Maha N. Abu Hajleh, Hamdi Nsairat, Sama Al Kazaz, Ali Al-Samydai, Hind Rasheed, Alia K. Ibrahim   +5 more
doaj   +1 more source